BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16905325)

  • 1. No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease.
    Di Maria E; Marasco A; Tartari M; Ciotti P; Abbruzzese G; Novelli G; Bellone E; Cattaneo E; Mandich P
    Neurobiol Dis; 2006 Nov; 24(2):274-9. PubMed ID: 16905325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease.
    Kishikawa S; Li JL; Gillis T; Hakky MM; Warby S; Hayden M; MacDonald ME; Myers RH; Gusella JF
    Neurobiol Dis; 2006 Nov; 24(2):280-5. PubMed ID: 16962786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between BDNF Val66Met polymorphism and age at onset in Huntington disease.
    Alberch J; López M; Badenas C; Carrasco JL; Milà M; Muñoz E; Canals JM
    Neurology; 2005 Sep; 65(6):964-5. PubMed ID: 16186551
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.
    Nazé P; Vuillaume I; Destée A; Pasquier F; Sablonnière B
    Neurosci Lett; 2002 Aug; 328(1):1-4. PubMed ID: 12123845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
    Mai M; Akkad AD; Wieczorek S; Saft C; Andrich J; Kraus PH; Epplen JT; Arning L
    BMC Med Genet; 2006 Nov; 7():79. PubMed ID: 17096834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at onset in Huntington's disease: replication study on the association of HAP1.
    Karadima G; Dimovasili C; Koutsis G; Vassilopoulos D; Panas M
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1027-8. PubMed ID: 22698993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.
    Marziniak M; Herzog AL; Mössner R; Sommer C
    J Neural Transm (Vienna); 2008 Sep; 115(9):1321-5. PubMed ID: 18478177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
    Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
    J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Tsuneki H; Kawasaki Y; Zhou SY; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Neurosci Lett; 2008 Apr; 435(1):34-9. PubMed ID: 18325670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of HD and UCHL-1 genes in Huntington's disease.
    Xu EH; Tang Y; Li D; Jia JP
    J Clin Neurosci; 2009 Nov; 16(11):1473-7. PubMed ID: 19683447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.
    Ribeiro L; Busnello JV; Cantor RM; Whelan F; Whittaker P; Deloukas P; Wong ML; Licinio J
    Neuroreport; 2007 Aug; 18(12):1291-3. PubMed ID: 17632285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Mariotti C; Lange HW; Weirich-Schwaiger H; Wenning GK; Seppi K; Melegh B; Havasi V; Balikó L; Wieczorek S; Zaremba J; Hoffman-Zacharska D; Sulek A; Basak AN; Soydan E; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Hum Genet; 2006 Sep; 120(2):285-92. PubMed ID: 16847693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition.
    Beste C; Baune BT; Domschke K; Falkenstein M; Konrad C
    Neuroscience; 2010 Mar; 166(1):178-84. PubMed ID: 20034542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
    Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
    J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.
    Petracca M; Di Tella S; Solito M; Zinzi P; Lo Monaco MR; Di Lazzaro G; Calabresi P; Silveri MC; Bentivoglio AR
    Eur J Neurol; 2022 Jul; 29(7):1940-1951. PubMed ID: 35357736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset Huntington's disease with 40-42 CAG expansion.
    Capiluppi E; Romano L; Rebora P; Nanetti L; Castaldo A; Gellera C; Mariotti C; Macerollo A; Cislaghi MG
    Neurol Sci; 2020 Apr; 41(4):869-876. PubMed ID: 31820322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset Huntington disease with intermediate CAG repeats: true or false?
    Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.